DEF 14AThe Ballot
Candel Therapeutics, Inc. files DEF 14A
Filed Sep 2, 2022 · 3y ago · Accession 0001193125-22-237187
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Candel Therapeutics, Inc.
- Ticker
- CADL
- CIK
- 1841387
- Form type
- DEF 14A
- Filing date
- Sep 2, 2022
- Report date
- Oct 13, 2022
- Document
- d392786ddef14a.htm
- Size
- 382 KB